vs
Side-by-side financial comparison of RENASANT CORP (RNST) and TANDEM DIABETES CARE INC (TNDM). Click either name above to swap in a different company.
RENASANT CORP is the larger business by last-quarter revenue ($273.8M vs $247.2M, roughly 1.1× TANDEM DIABETES CARE INC). RENASANT CORP runs the higher net margin — 32.2% vs -8.2%, a 40.5% gap on every dollar of revenue. Over the past eight quarters, RENASANT CORP's revenue compounded faster (29.3% CAGR vs 5.5%).
Renasant Bank is an American regional commercial financial institution based in Tupelo, Mississippi. The bank has more than 280 branches in Alabama, Florida, Georgia, Mississippi, Louisiana, Tennessee, North Carolina and South Carolina. Renasant Bank operates under the parent company Renasant Corporation and is affiliated with Renasant Nation, a platform through which they publish blogs and shows.
Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.
RNST vs TNDM — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $273.8M | $247.2M |
| Net Profit | $88.2M | $-20.4M |
| Gross Margin | — | 55.3% |
| Operating Margin | — | 37.6% |
| Net Margin | 32.2% | -8.2% |
| Revenue YoY | — | 5.5% |
| Net Profit YoY | 112.5% | — |
| EPS (diluted) | $0.94 | $-0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $273.8M | $247.2M | ||
| Q4 25 | $278.4M | $290.4M | ||
| Q3 25 | $269.5M | $249.3M | ||
| Q2 25 | $267.2M | $240.7M | ||
| Q1 25 | $170.7M | $234.4M | ||
| Q4 24 | $167.1M | $282.6M | ||
| Q3 24 | $220.3M | $244.0M | ||
| Q2 24 | $163.8M | $221.9M |
| Q1 26 | $88.2M | $-20.4M | ||
| Q4 25 | $78.9M | $-589.0K | ||
| Q3 25 | $59.8M | $-21.2M | ||
| Q2 25 | $1.0M | $-52.4M | ||
| Q1 25 | $41.5M | $-130.6M | ||
| Q4 24 | $44.7M | $755.0K | ||
| Q3 24 | $72.5M | $-23.3M | ||
| Q2 24 | $38.8M | $-30.8M |
| Q1 26 | — | 55.3% | ||
| Q4 25 | — | 57.7% | ||
| Q3 25 | — | 53.9% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 50.5% | ||
| Q4 24 | — | 55.7% | ||
| Q3 24 | — | 51.1% | ||
| Q2 24 | — | 50.8% |
| Q1 26 | — | 37.6% | ||
| Q4 25 | 34.8% | 2.9% | ||
| Q3 25 | 27.9% | -9.2% | ||
| Q2 25 | 1.0% | -21.5% | ||
| Q1 25 | 30.4% | -51.6% | ||
| Q4 24 | 29.8% | -0.2% | ||
| Q3 24 | 44.2% | -10.7% | ||
| Q2 24 | 29.6% | -13.9% |
| Q1 26 | 32.2% | -8.2% | ||
| Q4 25 | 28.4% | -0.2% | ||
| Q3 25 | 22.2% | -8.5% | ||
| Q2 25 | 0.4% | -21.8% | ||
| Q1 25 | 24.3% | -55.7% | ||
| Q4 24 | 26.8% | 0.3% | ||
| Q3 24 | 32.9% | -9.5% | ||
| Q2 24 | 23.7% | -13.9% |
| Q1 26 | $0.94 | $-0.30 | ||
| Q4 25 | $0.78 | $0.02 | ||
| Q3 25 | $0.63 | $-0.31 | ||
| Q2 25 | $0.01 | $-0.78 | ||
| Q1 25 | $0.65 | $-1.97 | ||
| Q4 24 | $0.70 | $0.00 | ||
| Q3 24 | $1.18 | $-0.35 | ||
| Q2 24 | $0.69 | $-0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.2B | $570.3M |
| Total DebtLower is stronger | $806.2M | — |
| Stockholders' EquityBook value | $3.9B | $132.4M |
| Total Assets | $27.1B | $1.2B |
| Debt / EquityLower = less leverage | 0.21× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.2B | $570.3M | ||
| Q4 25 | $1.1B | $292.7M | ||
| Q3 25 | $1.1B | $319.1M | ||
| Q2 25 | $1.4B | $315.4M | ||
| Q1 25 | $1.1B | $368.6M | ||
| Q4 24 | $1.1B | $438.3M | ||
| Q3 24 | $1.3B | $473.3M | ||
| Q2 24 | $851.9M | $452.4M |
| Q1 26 | $806.2M | — | ||
| Q4 25 | $499.8M | — | ||
| Q3 25 | $558.9M | — | ||
| Q2 25 | $557.0M | — | ||
| Q1 25 | $433.3M | — | ||
| Q4 24 | $430.6M | — | ||
| Q3 24 | $433.2M | — | ||
| Q2 24 | $428.7M | — |
| Q1 26 | $3.9B | $132.4M | ||
| Q4 25 | $3.9B | $155.2M | ||
| Q3 25 | $3.8B | $133.0M | ||
| Q2 25 | $3.8B | $133.3M | ||
| Q1 25 | $2.7B | $155.3M | ||
| Q4 24 | $2.7B | $263.1M | ||
| Q3 24 | $2.7B | $237.7M | ||
| Q2 24 | $2.4B | $233.9M |
| Q1 26 | $27.1B | $1.2B | ||
| Q4 25 | $26.8B | $881.1M | ||
| Q3 25 | $26.7B | $874.7M | ||
| Q2 25 | $26.6B | $875.7M | ||
| Q1 25 | $18.3B | $922.1M | ||
| Q4 24 | $18.0B | $967.7M | ||
| Q3 24 | $18.0B | $957.7M | ||
| Q2 24 | $17.5B | $937.5M |
| Q1 26 | 0.21× | — | ||
| Q4 25 | 0.13× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | 0.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RNST
| Net Interest Income | $223.6M | 82% |
| Noninterest Income | $50.3M | 18% |
TNDM
Segment breakdown not available.
